Media Releases

2023

01/03/2023

Proteomics nears agreement to sell kidney disease test in USA – The West Australian

01/03/2023

US update: PromarkerD licensing negotiations

15/02/2023

Proteomics inks five-year extension to British distribution agreement – The West Australian

15/02/2023

Distribution agreement for PromarkerD in Britain extended

03/01/2023

CPT PLA Reimbursement Code Approved in US for PromarkerD

2022

14/12/2022

UK NICE publishes Medtech Innovation Briefing on PromarkerD

11/11/2022

PromarkerD patent granted in Hong Kong

03/11/2022

Proteomics International to present at the Emerging ASX Gems Conference

20/10/2022

Precision diagnostics facility receives $2m funding boost

17/10/2022

Proteomics receives R&D tax incentive – AuManufacturing

17/10/2022

Proteomics receives $1.7 million in R&D tax incentive

29/09/2022

Cancer test boosts market hopes for Proteomics – The West Australian

27/09/2022

New Oesophageal Cancer Diagnostic shows strong performance

29/08/2022

Proteomics International develops non-invasive blood-based diagnostic for endometriosis – Clarivate BioWorld™

29/08/2022

Proteomics International Laboratories set to expand its commercial footprint in the US [VIDEO] – Proactive Investors

1
…
5
6
7
8
9
10
11
…
27